Australia
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
It also plans to double its headcount over the next 12 months.
It has also entered into a collaboration with The Pharmacy Guild of Australia for health service initiatives.
It has been approved as a prescription-only software-as-a-medical device in the US.
The company has received backing from the state government of Western Australia.
Also, I-MED will expand its deployment of 4DMedical's lung imaging tool across its network in Australia.
It has zoom, rotate, and annotate features to help specialists explain procedures to patients virtually.
Two variants of the Annalise CXR Edge products will be offered in Australia.
Their combined solution eliminates manual scheduling and paging.
The company develops a breakthrough device for detecting residual cancer tissues.